WHO urges countries to make drugs such as Mounjaro more accessible to people and asks drugs companies to lower prices
Weight loss drugs such as Mounjaro offer huge potential to tackle soaring obesity globally that will affect 2 billion people worldwide by 2030, the World Health Organization has said.
Their proven effectiveness in helping people lose weight means the medications represent “a new chapter” in how health services can treat obesity and the killer diseases it causes, the WHO added.
